The Cost Problem with Difluprednate

You prescribe Difluprednate because it works. It's one of the most potent topical ophthalmic corticosteroids available — superior corneal penetration, proven efficacy for post-surgical inflammation and uveitis, convenient four-times-daily dosing that outperforms higher-frequency regimens with older steroids.

But here's the problem your patients face: a single 5 mL bottle of brand-name Durezol costs $250–$400 at retail. Even the generic can run $45–$120 with a discount card — and with the ongoing generic shortage, many patients are forced to fill the brand at even higher prices.

When patients can't afford their medication, they don't fill it. Or they stretch doses. Or they stop early. The result? Rebound inflammation, treatment failure, and avoidable complications that cost everyone more in the long run.

This guide covers every tool available to help your patients afford Difluprednate — from manufacturer programs to discount cards to therapeutic alternatives — so you can prescribe with confidence that your patients can actually follow through.

What Your Patients Are Paying

Understanding the real-world cost landscape helps frame the conversation:

Brand-Name Durezol (0.05% emulsion, 5 mL)

• Cash price (no insurance): $250–$400
• Insured with Tier 3 copay: $50–$100+ depending on plan
• High-deductible health plans: Full retail until deductible is met

Generic Difluprednate (0.05% emulsion, 5 mL)

• Cash price without discount: ~$303 average retail
• With discount card: $45–$120
• Insured (Tier 1/2): $5–$30 copay

The Shortage Factor

Since April 2024, generic manufacturer Exelan has had Difluprednate on long-term back order with no estimated release date. This supply constraint has:

• Reduced pharmacy access to generic options
• Pushed more patients toward expensive brand-name Durezol
• Created price volatility across pharmacies

The result is that even patients with insurance may face unexpected out-of-pocket costs when their preferred generic isn't available.

Manufacturer Savings Programs

Novartis Copay Savings Card

Novartis offers a copay assistance program for commercially insured patients filling brand-name Durezol.

• Eligibility: Patients with commercial insurance (not government-funded programs like Medicare, Medicaid, or Tricare)
• Benefit: Reduces copay — specific dollar amount varies by program terms
• How to access: Visit copay.novartispharma.com or provide your patient with the program information
• Duration: Typically valid for one year, renewable

Provider tip: Keep copay card information in your EHR prescription templates or have front desk staff distribute cards at checkout. Patients are more likely to use savings programs when they're handed to them rather than told to search online.

Novartis Patient Assistance Foundation (NPAF)

For patients without insurance or with inadequate coverage, NPAF offers Durezol free of charge.

• Eligibility: Uninsured or underinsured patients who meet income criteria
• How to apply: Visit pap.novartis.com; applications require prescriber involvement
• Processing time: Typically 2–4 weeks after submission
• Duration: Usually 12 months, with renewal options

Provider tip: Assign a staff member to handle PAP applications. The process isn't complicated, but it requires a prescriber signature and some basic patient financial information. Having a designated "medication access coordinator" (even informally) dramatically increases PAP utilization.

Prescription Hope

Prescription Hope is a third-party organization that facilitates access to manufacturer assistance programs. They offer Durezol for a flat fee of $70/month.

• Eligibility: Patients earning under $40,000/year (individual) or $60,000/year (family)
• How it works: Prescription Hope applies to manufacturer programs on the patient's behalf and handles renewals
• Best for: Patients who qualify for manufacturer assistance but need help navigating the application process

Coupon and Discount Cards

Discount cards can significantly reduce the cost of generic Difluprednate. These are particularly useful for:

• Patients paying cash
• Patients whose insurance copay exceeds the discount price
• Patients in high-deductible plans who haven't met their deductible

Top Discount Card Options

• GoodRx: Widely recognized, easy for patients to use. Generic Difluprednate prices typically $45–$90 depending on pharmacy.
• SingleCare: Similar pricing to GoodRx. Accepted at most major pharmacies including CVS, Walgreens, and Walmart.
• RxSaver: Compares prices across pharmacies and provides printable or digital coupons.
• Optum Perks: United Health Group's discount card program. Competitive pricing on generics.
• BuzzRx: Free prescription discount card with no registration required.

Provider tip: Recommend that patients compare prices across multiple pharmacies using these tools. Difluprednate pricing can vary by $50+ between pharmacies in the same ZIP code. Independent pharmacies sometimes offer lower prices than chains.

Important Caveats

• Discount cards cannot be combined with insurance — it's one or the other per fill
• Patients should compare their insurance copay to the discount card price and use whichever is lower
• Discount card prices fluctuate and should be checked before each fill
• Some cards require the patient to ask the pharmacist to run it separately from insurance

Generic Alternatives and Therapeutic Substitution

When Difluprednate isn't affordable or available, having a clear substitution strategy is essential.

Generic Difluprednate

Generic Difluprednate is the first option and is therapeutically equivalent to brand Durezol. However, the ongoing shortage has made generic supply unreliable. When available, it's substantially less expensive with discount cards ($45–$120 vs. $250–$400 for brand).

Therapeutic Alternatives

If Difluprednate is unavailable or cost-prohibitive, consider these alternatives based on clinical scenario:

For post-surgical inflammation:

• Prednisolone Acetate 1% (Pred Forte): Available as a cheap generic ($10–$30). Requires more frequent dosing (4–8 times daily). First-line for many surgeons. Less potent but well-established efficacy.
• Dexamethasone 0.1% (Maxidex): Similar potency to Difluprednate. Available generically at reasonable cost. Good option when a strong steroid is needed and Difluprednate isn't accessible.

For mild to moderate inflammation or patients at high IOP risk:

• Loteprednol Etabonate 0.5% (Lotemax): Lower risk of IOP elevation. Available as gel, suspension, and ointment. Better choice for patients with glaucoma history or known steroid responders.
• Fluorometholone 0.1% (FML): Mildest option. Lower IOP risk. Best for surface inflammation rather than deep intraocular inflammation.

For a detailed comparison, refer patients to our guide on Difluprednate alternatives.

Provider tip: Consider building a "cost ladder" into your prescribing practice. Start with the most affordable effective option and step up only when clinically necessary. Document the rationale for choosing Difluprednate over less expensive alternatives — this can also support prior authorization appeals.

Building Cost Conversations into Your Workflow

Cost discussions shouldn't be an afterthought. Research consistently shows that medication affordability is a primary driver of adherence — and ophthalmology is no exception.

At the Point of Prescribing

• Ask about insurance and cost concerns before writing the prescription: "Do you have a prescription drug benefit? Have you had trouble affording medications in the past?"
• Use your EHR's real-time benefit check (RTBC) if available — tools like Surescripts or CoverMyMeds can show patient-specific cost estimates before you prescribe
• Offer the discount card information proactively — don't wait for the patient to get sticker shock at the pharmacy

Create a Medication Access Resource Sheet

Develop a one-page handout for Difluprednate that includes:

• Novartis copay card URL
• NPAF patient assistance application link
• Top 3 discount card options (GoodRx, SingleCare, RxSaver)
• Tips for finding the medication in stock during the shortage
• Link to Medfinder for Providers

At Follow-Up

• Ask if they filled the prescription: "Were you able to get the Difluprednate?" — a significant percentage of patients never fill post-surgical prescriptions due to cost
• Check adherence: If they're stretching doses or using it less frequently than prescribed, explore whether cost is the reason
• Reassess the medication choice: If a patient can't afford Difluprednate even with assistance programs, switching to a therapeutic alternative is better than suboptimal adherence

Designate a Cost Navigator

If your practice volume supports it, designate a team member (technician, medical assistant, or patient coordinator) as the point person for medication access. Their responsibilities:

• Processing manufacturer assistance applications
• Helping patients compare discount card prices
• Assisting with prior authorization paperwork
• Checking Medfinder for pharmacy availability during shortages
• Following up with patients who haven't filled prescriptions within 48 hours

Final Thoughts

Difluprednate is an outstanding medication that, unfortunately, comes with a price tag that blocks access for many patients. As a prescriber, you're uniquely positioned to bridge the gap between clinical efficacy and real-world affordability.

The tools exist — manufacturer programs, discount cards, patient assistance foundations, and therapeutic alternatives. The key is building these into your workflow so cost navigation happens automatically, not as an afterthought when a patient calls saying they can't afford their drops.

For provider-specific resources, visit Medfinder for Providers. For information on helping patients locate Difluprednate during the shortage, see our provider's guide to finding Difluprednate in stock.